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ABSTRACT  
Bioenhancers are chemical entities that are obtained from synthetic as well as natural sources. They are mainly used in formulation 
development to enhance the bioavailability of poorly solubilized drug molecule. The ideal characteristic of bioenhancers inc ludes inertness, 
nontoxic, cost effective and decrease the dose of active constituents. There are lots of natural bioenhancers available such as piperine quercetin 
niaziridin, genistein, glycrrhyzin, curcumin. The review focus on plant based bioenhancers and their active principle that produces those effects. 
There is a need of extensive study on natural bioenhancers which can be utilized in formulation development.  
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INTRODUCTION 
Drugs that are administered orally go through a dissolution 
process and then permeation across the gastric membrane 
before they can appear in the blood stream (1). The amount 
of drug that goes into the bloodstream from its site of 
administration is defined as its bioavailability (2). Solubility 
is defined as the property of a substance to dissolve itself 
into a solid, liquid or a gaseous solvent to form a 
homogeneous solution of it. Solubility of a drug in gastric 
media is an essential requirement for an orally administered 
drug to be absorbed adequately (3).  The majority of factors 
that affect the bioavailability of a drug other than solubility 
and permeability include the dissolution rate of the drug, 
first-pass effect, pre-systemic metabolism of the drug in any 
other organ and susceptibility to efflux mechanisms(4). 
Solubility in the gastric media is a major problem associated 
with orally administered drugs that leads to erratic 
bioavailability and possible toxicity in the living system; 
making solubility of new drug molecules one of the crucial 
challenges for formulation scientists(3). In spite of these 
issues, the oral route of drug administration has been the 
most sought after route due to its ease of administration, 
high patient compliance, cost-effectiveness, least need for 
maintenance of sterile conditions, and flexibility in design of 
the dosage form(5).  
The use of bio enhancers is a promising approach to 
overcome the issues related to bioavailability. A bioenhancer 
enhances the bioavailability of a drug molecule without 
causing any pharmacological activity of its own(6).Bio 
enhancers of herbal origin have gained interest recently and 
many herbal compounds including quercetin, genistein, 
naringin, sinomenine, piperine, glycyrrhizin and nitrile 
glycoside have proved their efficacy in increasing the 
bioavailability of the drugs with which they are 
combined(7). 
BARRIERS TO DRUG ABSORPTION 
For a drug to exert its biological actions, it is essential for it 
to reach to the systemic circulation (7). However, the drug 
has to cross various biological barriers before it reaches to 
the bloodstream. The epithelium of intestine consists of 
several physiological barriers to the absorption of drug. 
Solubility and permeability of a drug are important barriers 
to its absorption(8). The aqueous layer present on the 
intestinal epithelium serves as a crucial barrier for the 
absorption of drugs due to their hydrophilic nature (9). 
Generally, drugs with sizemore than 0.4 nm seldom pass 
through the aqueous channels(7). Results from recent 
investigations have also revealed that P-glycoprotein, a type 
of energy dependent efflux pump plays important roles in 
preventing the entry of drug into systemic 
circulation(10).The presence of both Cytochrome P450 
(CYP) 3A and P-glycoprotein and their combined action on 
the enterocytes is also assumed to be a limiting factor in oral 
drug absorption (11). Importantly, the inhibition of these 
Verma et al                                                                                                              Journal of Drug Delivery & Therapeutics. 2019; 9(6):201-205 
ISSN: 2250-1177                                                                                  [202]                                                                                 CODEN (USA): JDDTAO 
proteins have shown enhanced bioavailability of drug in 
clinical studies (12).Moreover, the thick cytoplasm of the 
cells responsible for the absorption is also acts as a potential 
barrier to the transfer of drug from the site of absorption to 
the systemic circulation (9). 
BIOENHANCERS 
A herbal bioenhancer is an agent of herbal origin that has the 
capability to enhance that bioavailability of a drug with 
which it is combined, without causing any pharmacological 
activity of its own (13).Adding a bioenhancer to a drug helps 
to reduce drug dosage, drug cost, incidences of drug 
resistance and risks of adverse drug reaction. Most 
importantly, a bioenhancer improves the efficacy of a drug 
by enhancing its bioavailability. In addition, adding a 
bioenhancer also reduces raw material requirement during 
pharmaceutical manufacturing(14). Major categories of 
drugs that have shown increased bioenhancement include 
the drugs acting on cardiovascular system (CVS), respiratory 
system, central nervous system (CNS), gastrointestinal 
tract(GIT), antibiotics and anticancer agents. Some examples 
where addition of bioenhancers have significantly improved 
the drug efficacy include tetracyclines, sulfadiazine, vasicine, 
rifampicin, isoniazid,  pyrazinamide, ethambutol, phenytoin, 
phenobarbitone, carbamazepine, nimesulide, indomethacin 
beta-carotene, coenzyme Q10 (CoQ10), ciprofloxacin, 
curcumin, dapsone, amino acids, glucose and several other 
classes of drugs(6). 
MECHANISM OF BIOENHANCER ACTION 
Bioenhancers are known to act through several mechanisms 
of action. Generally a bioenhancer increases the 
bioavailability of the accompanied drug by acting on 
gastrointestinal tract to enhance its absorption or by acting 
on drug metabolism process either by inhibiting or reducing 
the rate of biotransformation of drugs in the liver or 
intestines. A bioenhancer may also additionally modify the 
signaling processes between host and pathogen by 
increasing the accessibility of the drugs to the pathogens or 
by inhibiting the active transporters located in various 
locations such as P-glycoprotein (P-gp) is an efflux pump 
which pumps out drugs and prevent it from reaching the 
target site. Bioenhancers in such case act by inhibiting the P-
gp efflux mechanisms that are frequently observed in case of 
antimalarials, anticancers and antimicrobials (15).In a study 
carried out on a natural bioenhancer molecule, Piperine, to 
evaluate the bioenhancer mediated changes in the 
permeability of rat intestinal epithelial cells, the status of γ-
glutamyl transpeptidase activity, uptake of amino acids, and 
lipid peroxidation, piperine(25–100 M) significantly 
stimulated γ-glutamyl transpeptidase activity, enhanced the 
uptake of radiolabelled l-leucine, l-isoleucine, and l-valine, 
and increased lipid peroxidation in freshly isolated epithelial 
cells of rat jejunum. In the presence of benzyl alcohol, an 
enhanced γ-glutamyl transpeptidase activity due to piperine 
was maintained. These results suggested that piperine may 
interact with the lipid environment to produce effects which 
lead to increased permeability of the intestinal cells(13). 
A bioenhancer may also act by decreasing the elimination 
process in the body thereby extending the residence time of 
drug in the body or by inhibiting the drug metabolizing 
enzymes like CYP 3A4, CYP1A1, CYP1B2, CYP2E1, in the 
liver, gut, lungs, and various other locations. Inhibiting the 
renal clearance by preventing glomerular filtration, active 
tubular secretion by inhibiting P-gp and facilitating passive 
tubular reabsorption can also be an employed mechanism of 
a bioenhancer molecule(16, 17). 
 
NATURAL BIOENHANCERS 
Natural bioenhancers of both plant and animal origins such 
as piperine, quercetin, genistein, naringin, sinomenine, 
glycyrrhizin, curcumin, lysergol, allicin, niaziridinetc. have 
been investigated and reported to possess bioenhancer 
activities. Several mechanisms of actions for the 
bioavailability enhancement of these bioenhancers have 
been proposed including, but not limited to, modification of 
acid secretion and blood supply to the GIT, modification of 
bile acid secretion, modification of gastric emptying time, 
GIT motility and transit, modification of GIT membrane 
permeability, inhibition of drug metabolizing enzymes 
(DMEs) in gut wall and liver, stimulation of specific enzymes 
and/or transporters, etc. However, predominant 
mechanisms of action of these bioenhancers are enhancing 
the absorption by increased blood supply of the GIT and 
reducing biotransformation and efflux by modulation of 
DMEs and efflux drug transporters (EDTs) 
respectively(18).Some of the natural bioenhancers that are 
employed frequently in pharmaceutical manufacturing are 
discussed in this review. 
Piperine 
Piperine is the most intensively investigated bioenhancer. It 
is an alkaloid obtained from black and long peppers (P. 
nigrum Linn and P. longum Linn). Piperine has been reported 
to enhance the bioavailability of various drugs and 
nutraceuticals. Piperine act is through multiple mechanisms 
including the inhibition of DMEs, EDTs, stimulation of gut 
amino acid transporters, increased intestinal glucoronic acid 
secretion etc. Piperine is found to inhibit DMEs that include 
arylhydrocarbon hydroxylase (AHH), uridine diphosphate-
glucoronyl transferase (UDP-GT), ethylmorphine-
Ndemethylase, 7-ethoxycoumarin-O-deethylase, 3-hydroxy-
benzopyrene glucoronidation, UDP-glucose dehydrogenase 
(UDP-GDH), 5-lipooxygenase, cyclooxygenase-1, and 
cytochrome P450.Most importantly, piperine inhibits P-gp 
and CYP3A4 that are expressed in enterocytes of the gut wall 
and hepatocytes of the liver that contribute to a major extent 
of pre-systemic elimination of many drugs resulting in poor 
bioavailability.  
N
O
O
O
Piperine  
Quercetin 
Quercetin is a plant derived flavonoid that is found mainly in 
citrus fruits, vegetables, leaves, and grains. Quercetin is 
known for diverse set of biological propertiesthat include 
antioxidant, radical scavenging, antiinflammatory, 
antiatherosclerotic, anticancer, and antiviral effects. 
Quercetin has been reported to enhance the bioavailability 
of various drugs including, pioglitazone, diltiazem, digoxin, 
paclitaxel, tamoxifen, verapamil, etoposide and 
epigallocatechin-3-gallate (EGCG). Quercetin is an inhibitor 
of CYP3A4 and a modulator of P-glycoproteins and MDR 
transporters (13, 16, 18). 
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Niaziridin 
Niaziridin is reported to enhance the bioavailability of a 
number of antibiotics. These include rifampicin, ampicillin, 
tetracycline, nalidixic acid etc. against both gram-ve and 
gram +ve bacteria.Niaziridin has resulted in enhanced 
bioavailability of antibiotics against gram-vebecteriaE. Coli. 
Moreover, combining Niaziridin with antibiotics has also 
increased the spectrum of the latter against various gram+ve 
bacteria that include M. smegmatis and Bacillus subtilis most 
importantly. It is reported to enhance the activity of 
rifampicin, ampicillin, tetracycline, and nalidixic acids by 
1.2–19-fold against the Gram-positive strains and the 
activity of azole antifungal drugs such as clotrimazole 
against Candida albicans by 5-6-fold. However, the 
antifungal activity enhancement by Niaziridin is possible at 
relatively higher concentration (10μg/mL) of the compound. 
Niaziridin is also known to facilitate the uptake of nutrients 
like Vitamin B12 through the intestinal gut membrane in 
combination(18, 19). 
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Naringin 
Naringin is a flavonoid glycoside isolated mainly from 
grapefruit, apples, onions and tea. It acts as a bioenhancer by 
inhibiting the metabolizing enzymes such as CYP3A4 and 
CYP3A1/2. It is also reported to act through the inhibition of 
efflux pump P-gp. Naringin is reported to efficiently enhance 
the bioavailability of a number of drugs. These include 
diltiazem, verapamil, paclitaxel etc. 
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Genistein 
Genistein is a phytoestrogen and an isoflavone flavonoid 
found in dietary plants such as soybean and kudzu (Glycine 
max and Pueraria lobata). It exhibits its bioenhancing 
properties on various drugs including paclitaxel and EGCG 
through the inhibition of CYP3A, P-gp, MRP2, and BCRP 
transporters. Although gensitein is known to inhibit various 
efflux transporters and metabolizing enzymes, its use is 
restricted due to its tumor promoting effects that are evident 
from in vivo reports. 
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Glycyrrhizin 
Glycyrrhizin is a triterpenoid saponin glycoside isolated 
fromliquorice (Glycyrrhiza galbra L.).Glycyrrhizin has 
demonstrated bioenhancing activity when combined with 
various antimicrobial agents including rifampicin, 
tetracycline, nalidixic acid, etc. The anticancer activity of 
Paclitaxel increases manifolds when it combines with 
glycyrrhizin. Glycyrrhizin is also reported to enchance (2 to 
6 fold) transport of vitamins B1 and B12 across the gut 
membraneIt majorly acts through the inhibition of intestinal 
P-gp transporters. However, the major determinant of its 
action is the rate and extent of biotransformation of 
glycyrrhizin to glycyrrhizic acid by intestinal β-
glucuronidase(16, 20). 
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Curcumin 
Curcumin is a curcuminoid obtained from turmeric 
(Curcuma longa). It is an efficient bioenhancer for 
antimicrobial and anticancer drugs such as norfloxacin, 
docetaxel etc.Curcumin inhibits the actions of metabolizing 
enzymes CYP3A4 in the liver. However, curcumin also 
inhibits drug metabolizing enzymes (DMEs) non-specifically. 
It is also reported to inhibit the P- glycoproteins (P-gp) in 
the gut walls (13, 21).  
O O
OH
OCH3
OH
OCH3 Curcumin  
Verma et al                                                                                                              Journal of Drug Delivery & Therapeutics. 2019; 9(6):201-205 
ISSN: 2250-1177                                                                                  [204]                                                                                 CODEN (USA): JDDTAO 
ZingiberOfficinale(Ginger) 
One of the most useful dietary ingredients, a spice common 
in Indian Kitchen Zingiber officinalis (Zingiberaceae) has 
shown effective bio-enhancement. A patent invention 
suggested that ginger extract helps to enhance 
bioavailability of several drugs. It has significant 
bioenhancing capabilities with a number of drugs that 
includes antibiotics such asfluoroquinones, penicillins, 
cephalosporins; antifungals such as fluconazole, 
ketoconazole, acyclovir, zidovudine; anticancer drugs such 
as methotrexate, 5- fluorouracil; cardiovascular drugs such 
as amlodipine, lisinopril and anti-histaminic salbutamol(22, 
23). 
CH3
O OH
OH
H3CO
Gingerol
 
Lysergol 
Lysergol is alkaloidal phytoconstituent obtained from 
Morning Glory Plant (Ipomoea spp.). It is reported to 
enhance bacteriocidal effects of different antibiotics against 
bacteria and is a promising herbal bioenhancer. It is also 
isolated from higher plants includingRiveacorymbosa, 
Ipomoea violacea, and Ipomoea muricata. In various other 
studies, lysergol is reported to enhance the bioavailability of 
different drugs like rifampicin, tetracycline and ampicillin. It 
is found effective against broad spectrum microbes, Gram-
positive and Gram-negative, consisting E. coli, B. subtilis, M. 
smegmatis and other similar microbes. In another study, 
lysergol improved the bioavailability of berberine after oral 
administration in Sprague-Dawley rats (13, 24). 
N
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Allicin 
Allicin is an allyl sulphur compound obtained from garlic 
(Allium sativum).Allicin is reported to be an enhancerof the 
fungicidal activity of Amphotericin B against pathogenic 
fungi includingCandida albicans, Aspergillusumigatus and 
yeast Saccharomyces cerevisiae.Allicin enhances 
Amphotericin Binduced vacuole membrane damage by 
inhibiting ergosterol accumulation from the plasma 
membrane to the vacuole membrane(16, 23, 25). 
CH2
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+
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Aloevera (Aloe) 
Aloe, a perennial and succulent xerophyte consist of several 
phytoconstituents’ that is widely  used in both human and 
veterinary medicine for its immunomodulatory, wound and 
burn healing, hypoglycemic, anticancer, gastro-protective, 
antifungal, and anti-inflammatory effects. The ethanolic 
extract of Aloe verais found to augment the hypoglycemic 
effect of glipizide in streptozotocin induced diabetic rats. 
Due to its cytoprotective effects on gastric mucosa through 
induction of endogenous prostaglandin production, 
concominant use of Aloe vera and pantoprazole for the 
gastroesophageal reflux symptoms in mustard gas victims 
were found to be improved compared to single treatments. 
(26). 
DISCUSSION AND CONCLUSION 
The origin of bioenhancers is based on traditional system of 
Indian medicine. The earliest use of bioenhancers is 
mentioned in Charaka, Sushruta and other apothecaries in 
traditional system of medicine.The concept of 
bioenhancement is useful in curbing the rising drug cost, 
toxicity, and other adverse effects, and thus may ultimately 
have a positive influence on the national economy. It 
satisfies all necessary criteria to be considered as an ideal 
drug excipient. It is safe, effective, economical, easily 
procured, non-addictive, and has a widely-based effect on 
several classes of drug. Hence, it has been proved that novel 
drug delivery system of herbal as well as of chemical origin 
can be used to increase the bioavailability of the 
componunds or their respective constituents (in case of 
herbal extracts). 
Medicinal plants with bioenhancing potentials require 
extensive exploration to improve the current approaches of 
drug delivery. Bioenhancers are efficient tools thatto reduce 
the dose of the drugs as well as and the duration of the 
treatment which is especially important for economic 
outcomes and health outcomes in humans. Bioenhancers 
also attenuate the drug resistance or related adverse 
reactions which are of prime importance in case of cancer 
treatment. Eventhough, the major known herbal 
bioenhancers are discussed in this review, 
variousphytoactive compounds and plant extracts are 
further required yet to be exploited with their mechanism of 
action and complex drug interactions.  
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